Latest Operational Cash Flow News

Page 35 of 143
DXN Limited reported a 63% revenue decline in Q2 FY26 due to project delays but bolstered its future outlook with a $15 million backlog and a strategic joint venture in Indonesia.
Sophie Babbage
Sophie Babbage
29 Jan 2026
Bioxyne Limited has delivered a record-breaking second quarter in FY2026, posting $17.2 million in revenue and expanding its footprint into key international markets. The company’s growth is underpinned by new contracts, innovative psychedelics products, and strategic government funding.
Victor Sage
Victor Sage
29 Jan 2026
Wellnex Life reports a significant turnaround with a 31.5% revenue increase and near break-even operating cash flow in the December quarter, driven by strategic brand consolidation and cost discipline.
Ada Torres
Ada Torres
29 Jan 2026
Liontown Limited has successfully transitioned to 100% underground mining at Kathleen Valley, delivering a 37% increase in underground production and a 91% jump in quarterly revenue. The company is on track to reduce costs and boost recoveries as it targets a steady-state underground run-rate.
Maxwell Dee
Maxwell Dee
29 Jan 2026
Elixinol Wellness Ltd reported a 9.5% revenue increase in Q4 FY25 alongside a 30% cut in operating costs, achieving its first underlying operating cash flow positive quarter. The company’s strategic acquisitions and e-commerce growth underpin a clear path to profitability.
Victor Sage
Victor Sage
29 Jan 2026
Saferoads Holdings Limited reported a modest rise in quarterly sales and a half-year net profit of approximately $511k, while progressing regulatory approval for its innovative HV2 barrier.
Victor Sage
Victor Sage
29 Jan 2026
SRJ Technologies has completed the first phase of its growth strategy and is now advancing into market penetration with a significant $23.8 million joint venture in the Middle East and a key board appointment.
Maxwell Dee
Maxwell Dee
29 Jan 2026
Freedom Care Group Holdings reports a modest cash increase to $0.5 million but continues to grapple with delayed payments from the NDIA, while exploring options to relist on the ASX.
Ada Torres
Ada Torres
29 Jan 2026
Mayne Pharma delivered a robust FY25 performance with a 105% surge in underlying EBITDA and launched key dermatology products as it outlines a strategic growth path for FY26.
Victor Sage
Victor Sage
29 Jan 2026
Appen Limited delivered a robust Q4 FY25, driven by explosive growth in its China segment and strong gains in generative AI projects globally, boosting revenue and profitability significantly.
Sophie Babbage
Sophie Babbage
29 Jan 2026
Urbanise.com Limited reported a 22% revenue increase in Q2 FY2026, driven by its strategic partnership with National Australia Bank and ongoing development of its Data and Payments Integration Services platform. Despite short-term cash outflows, the company targets positive operating cash flow by FY2027.
Sophie Babbage
Sophie Babbage
29 Jan 2026
BetMakers Technology Group reports a robust Q2 FY26 with 14.1% revenue growth and a $2.7 million positive Adjusted EBITDA, underpinned by key partnerships and margin expansion.
Sophie Babbage
Sophie Babbage
29 Jan 2026